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A 41-year-old man was referred to our center because of
two episodes of resuscitated cardiac arrest over 3 months. His
medical and family histories were unremarkable, except for
mild nocturnal palpitations. Rhythm recorded during resus-
citation was ventricular fibrillation (Fig. 1A). Resting ECG
showed normal sinus rhythm, normal axis, PR interval of
160 msec, QRS duration of 103 msec, and QT interval of 350
msec. A prominent J wave and ST-segment elevation was seen
in right precordial leads (Fig. 1B). No evidence of structural
heart disease was found. Resting ECG was not typical for
Brugada syndrome, thus pharmacologic provocation was per-
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Figure 1. A: This rhythm strip (ventricular fibrillation) recorded from the patient during cardiopulmonary resuscitation. B and C illustrate conversion of
saddle-back ST-segment elevation in right precordial leads to typical coved-type pattern following procainamide infusion, respectively. D: Shows ST-segment
normalization following quinidine administration.
formed. Procainamide infusion (10 mg/kg intravenous over
10 minutes) unmasked coved type ST-segment elevation in
right precordial leads confirming the diagnosis of Brugada
syndrome (Fig. 1C). Because of aborted cardiac death and
typical Brugada changes in provoked ECG, a single chamber
ICD (Marquis VR 7230, Medtronic Inc., Minneapolis, MN,
USA) was implanted. Ten days after implantation, the patient
experienced nine episodes of ICD discharges over 2 days
(mostly during the sleeping hours). All ICD discharges were
appropriate and successfully terminated all ventricular fibril-
lation (VF) episodes. Finally, we decided to administer slow-
release oral quinidine (900 mg/day) for control of electrical
storm. Following quinidine administration, ECG abnormal-
ities normalized (Fig. 1D), unifocal PVCs were suppressed
and nocturnal palpitations relieved. Noninvasive electrophys-
iologic study performed via ICD failed to induce any ventric-
ular tachyarrhythmias. During the 19-month follow-up, the
patient has been symptom-free and no ICD discharges re-
ported.
